Sort by
Refine Your Search
-
access to state-of-the-art facilities. Join us in our mission to advance our understanding of alveolar development, homeostasis, regeneration, and pathology. Your valuable contributions will significantly
-
connectivity supporting long-term memory formation. Perform in vivo patch-clamp recordings with cell-type specific access to characterize the cellular and circuit mechanisms of learning and memory. Develop and
-
understanding of the mechanisms of bnAb induction during natural infection. Dr. Williams has been awarded a NIH UM1 grant to develop new vaccine strategies that can induce more protective immune responses in
-
collaborative and integrated with multiple cores (within Duke) and collaborators in other US institutions. Work Performed Confer with the principal investigator in developing plans for research projects. Perform
-
, and apply Crainbow mouse models that express multiple HER2 isoforms — wild-type (WT), D16, and p95 which are essential reagents for the laboratory’s DoD funded program. Minimum Requirements: Ph.D
-
calculation of data. Obtain, prepare, mount and stain tissue, blood and other substances for microscopic examinations. Prepare culture media, chemicals, reagents and solutions. Assist in the development of new
-
may include teaching responsibilities. The appointment is generally preparatory for a full time academic or research career. The appointment is not part of a clinical training program, unless research
-
manuscript development and reporting of research results for the project (20% • Support mentoring of graduate students in the laboratory (10%) Term: This is a full time position available immediately with a
-
behavioral data will be viewed favorably. • Applicants’ ideas about how their research program could contribute to research in the Lab will also be a plus. Position Details: This position will be in-person
-
. Postdoctoral Associate – Regenerative CAR T Therapy for Duchenne Muscular Dystrophy This Postdoctoral Associate will serve on a project focused on developing regenerative CAR T-based therapeutic strategies